Metagenomi Therapeutics, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.220
-0.010 (-0.81%)
At close: Aug 17, 2026, 4:00 PM EDT
1.230
+0.010 (0.82%)
After-hours: Aug 17, 2026, 7:30 PM EDT
Metagenomi Therapeutics Market Cap
Metagenomi Therapeutics has a market cap or net worth of $46.09 million as of August 17, 2026. Its market cap has decreased by -33.98% in one year.
Market Cap
46.09M
Enterprise Value
-36.86M
1-Year Change
-33.98%
Ranking
Category
Stock Price
$1.22
ChartMarket Cap Chart
Since the IPO on February 9, 2024, Metagenomi Therapeutics's market cap has decreased from $562.92M to $46.09M, a decrease of -91.81%. That is a compound annual growth rate of -62.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 46.09M | -24.23% |
| Dec 31, 2025 | 60.83M | -54.98% |
| Dec 31, 2024 | 135.10M | -76.00% |
| Feb 9, 2024 | 562.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| aTyr Pharma | 50.90M |
| Instil Bio | 49.92M |
| Mereo BioPharma Group | 49.14M |
| Context Therapeutics | 48.72M |
| Veraxa Biotech AG | 46.90M |
| Grace Therapeutics | 45.44M |
| Veru Inc. | 44.84M |
| Seres Therapeutics | 44.84M |